SCHEMBL23749552

SCHEMBL23749552

CCOc1ccn(Cc2ccccc2)c(=O)c1C(=O)Cl

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.54
MAPT P10636 3/20 0.47
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
RECQL P46063 1/20 0.47
POLB P06746 3/20 0.46
THRB P10828 1/20 0.46
BRD4 O60885 2/20 0.45
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44
BRDT Q58F21 1/20 0.44
EGLN1 Q9GZT9 1/20 0.43
ALDH1A1 P00352 1/20 0.43
NOTUM Q6P988 1/20 0.43
TP53 P04637 2/20 0.42
CYP2D6 P10635 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30030303 0.88 MAPK14 (0.53) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL23749288 0.87 MAPK14 (0.48) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL15506048 0.80 MAPK14 (0.48) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL28554633 0.75 L3MBTL1 (0.39) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL23749427 0.73 PTGS1 (0.39) MAPTKMT2APOLBALDH1A1TP53
SCHEMBL12502722 0.73 NOTUM (0.58) MAPK14MAPTKDM4EPOLBBRD4
SCHEMBL12502932 0.73 NOTUM (0.55) MAPK14MAPTKDM4EBRD4BRD2
SCHEMBL1137261 0.72 NOTUM (0.56) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL11516666 0.71 L3MBTL1 (0.52) MAPTKDM4EMEN1KMT2ARECQL
SCHEMBL23749324 0.71 MET (0.41) MAPTTHRBALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2025-01-21 US disclosed
CN-111196814-B Aromatic ring-linked dioxane quinazoline or quinoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2022-12-06 CN disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed
CN-111196814-A Aromatic ring connecting dioxane quinazoline or quinoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2020-05-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF MERTK, AXL, TYRO3 MAPK14 485/4885MAPT 2222/4885KDM4E 1245/4885
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors MERTK, AXL, TYRO3 MAPK14 428/4885MAPT 2170/4885KDM4E 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.